These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 20500450
1. Nasu-Hakola disease: The first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology. Kaneko M, Sano K, Nakayama J, Amano N. Neuropathology; 2010 Oct; 30(5):463-70. PubMed ID: 20500450 [Abstract] [Full Text] [Related]
2. C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation. Solje E, Hartikainen P, Valori M, Vanninen R, Tiihonen J, Hakola P, Tienari PJ, Remes AM. Neurobiol Aging; 2014 Jul; 35(7):1780.e13-7. PubMed ID: 24612676 [Abstract] [Full Text] [Related]
10. Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains. Satoh J, Kino Y, Motohashi N, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K. Neuropathology; 2015 Dec; 35(6):529-37. PubMed ID: 26087043 [Abstract] [Full Text] [Related]
14. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains. Satoh J, Tabunoki H, Ishida T, Yagishita S, Jinnai K, Futamura N, Kobayashi M, Toyoshima I, Yoshioka T, Enomoto K, Arai N, Arima K. Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401 [Abstract] [Full Text] [Related]
15. Phenotypic Expansion in Nasu-Hakola Disease: Immunological Findings in Three Patients and Proposal of a Unifying Pathogenic Hypothesis. Errichiello E, Dardiotis E, Mannino F, Paloneva J, Mattina T, Zuffardi O. Front Immunol; 2019 Aug; 10():1685. PubMed ID: 31396216 [Abstract] [Full Text] [Related]
16. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy): First report from India. Chepuru R, Shaik AJ, Tandra SR, Gaddamanugu P, Alladi S, Kaul S. Neurol India; 2018 Aug; 66(2):538-541. PubMed ID: 29547188 [No Abstract] [Full Text] [Related]
17. Gray matter lesions in Nasu-Hakola disease: a report on three autopsy cases. Aoki N, Tsuchiya K, Togo T, Kobayashi Z, Uchikado H, Katsuse O, Suzuki K, Fujishiro H, Arai T, Iseki E, Anno M, Kosaka K, Akiyama H, Hirayasu Y. Neuropathology; 2011 Apr; 31(2):135-43. PubMed ID: 20880319 [Abstract] [Full Text] [Related]
18. Neuropathological Alzheimer's Disease Lesions in Nasu-Hakola Disease with TREM2 Mutation: Atypical Distribution of Neurofibrillary Changes. Maderna E, Visonà S, Bolcato V, Redaelli V, Caroppo P, Montalbetti L, Giaccone G, Osculati A. J Alzheimers Dis; 2021 Apr; 79(1):25-30. PubMed ID: 33216037 [Abstract] [Full Text] [Related]
19. The case of a 43-year old Turkish male patient with Nasu-Hakola disease. Maner F, Ipekçioğlu D, Karamustafalıoğlu N, Karagöz Sakallı N, Cetinkaya O, Ilnem MC, Konuk N. Asian J Psychiatr; 2013 Dec; 6(6):631-2. PubMed ID: 24309893 [No Abstract] [Full Text] [Related]
20. Nasu-Hakola disease as suspected cause for bone disease and dementia. Sahebari M, Abbasi B, Akhondpour Manteghi A, Abdollahi N. J Clin Rheumatol; 2014 Apr; 20(3):160-2. PubMed ID: 24662559 [Abstract] [Full Text] [Related] Page: [Next] [New Search]